Severe cholestasis related to itraconazole for the treatment of onychomycosis Academic Article Article uri icon

Overview

MeSH Major

  • Endoscopy, Digestive System
  • Needles
  • Pancreatic Ducts
  • Pancreaticojejunostomy

abstract

  • We describe a case of prolonged cholestasis temporally associated with the use of itraconazole for onychomycosis. Peak bilirubin level of 32.0 mg/dl was documented approximately 2 months after discontinuation of the patient's itraconazole therapy, with symptoms of cholestasis persisting more than 1 month after the peak in bilirubin. Physicians should be aware of the potential for severe cholestasis associated with itraconazole usage.

publication date

  • December 1999

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1016/S0002-9270(99)00682-6

PubMed ID

  • 10606333

Additional Document Info

start page

  • 3632

end page

  • 3

volume

  • 94

number

  • 12